MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis

作者: Wei Yan , Rui Li , Yanwei Liu , Pei Yang , Zheng Wang

DOI: 10.18632/ONCOTARGET.2679

关键词:

摘要: MicroRNAs (miRNAs) are directly involved in the progression various cancers. To date, no systematic researches have been performed on expression pattern of miRNA during from low grade gliomas to anaplastic or secondary glioblastomas and those prognostic miRNAs glioblastomas. In present study, high-throughput microarrays were used measure levels 116 samples different stages glioma. We found that totally altered when progressed However, similar level. Furthermore, we developed a five-miRNA signature (two protective miRNAs-miR-767-5p, miR-105; three risky miRNAs: miR-584, miR-296-5p miR-196a) could identify patients with high risk unfavorable outcome regardless histology type. It should be highlighted can also who had TCGA Proneural glioblastomas, but not Neural, Classical Mesenchymal Taken together, our results demonstrate patterns malignant novel classifier, signature, serve as marker for patient stratification gliomas, Secondary

参考文章(21)
Hae Kyung Lee, Susan Finniss, Simona Cazacu, Efrat Bucris, Amotz Ziv-Av, Cunli Xiang, Kevin Bobbitt, Sandra A. Rempel, Laura Hasselbach, Tom Mikkelsen, Shimon Slavin, Chaya Brodie, Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. Oncotarget. ,vol. 4, pp. 346- 361 ,(2013) , 10.18632/ONCOTARGET.868
Swapna Asuthkar, Kiran Kumar Velpula, Chandramu Chetty, Bharathi Gorantla, Jasti S. Rao, Epigenetic Regulation of miRNA-211 by MMP-9 Governs Glioma Cell Apoptosis, Chemosensitivity and Radiosensitivity Oncotarget. ,vol. 3, pp. 1439- 1454 ,(2012) , 10.18632/ONCOTARGET.683
Maria Carmela Speranza, Véronique Frattini, Federica Pisati, Dimos Kapetis, Paola Porrati, Marica Eoli, Serena Pellegatta, Gaetano Finocchiaro, NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma Oncotarget. ,vol. 3, pp. 723- 734 ,(2012) , 10.18632/ONCOTARGET.547
Michiel Smits, Jonas Nilsson, Shahryar E. Mir, Petra M. van der Stoop, Esther Hulleman, Johanna M. Niers, Phillip C. de Witt Hamer, Victor E. Marquez, Jacqueline Cloos, Anna M. Krichevsky, David P. Noske, Bakhos A. Tannous, Thomas Würdinger, miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis Oncotarget. ,vol. 1, pp. 710- 720 ,(2010) , 10.18632/ONCOTARGET.205
Qiang Zhao, Jianguo Sun, Cox Survival Analysis of Microarray Gene Expression Data Using Correlation Principal Component Regression Statistical Applications in Genetics and Molecular Biology. ,vol. 6, pp. 1- 16 ,(2007) , 10.2202/1544-6115.1153
Dong Wang, Chengxiang Qiu, Haijun Zhang, Juan Wang, Qinghua Cui, Yuxin Yin, Human MicroRNA Oncogenes and Tumor Suppressors Show Significantly Different Biological Patterns: From Functions to Targets PLoS ONE. ,vol. 5, pp. e13067- ,(2010) , 10.1371/JOURNAL.PONE.0013067
Lei Shi, Zihao Cheng, Junxia Zhang, Rui Li, Peng Zhao, Zhen Fu, Yongping You, hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Research. ,vol. 1236, pp. 185- 193 ,(2008) , 10.1016/J.BRAINRES.2008.07.085
Glen Kristiansen, Klaus Jung, Annika Schaefer, Monika Jung, Hans-Joachim Mollenkopf, Ina Wagner, Carsten Stephan, Florian Jentzmik, Kurt Miller, Michael Lein, Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. International Journal of Cancer. ,vol. 126, pp. 1166- 1176 ,(2009) , 10.1002/IJC.24827
R Schickel, B Boyerinas, S-M Park, M E Peter, MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death Oncogene. ,vol. 27, pp. 5959- 5974 ,(2008) , 10.1038/ONC.2008.274